Research Alzheimer's Disease Research Center

  • Call Us 617-358-4133
  • Email Us joinadc@bu.edu
Menu Search
  • Home
  • Get Involved
    • Join A Study
    • Common Questions About Participating in Research
    • Clinical Trials
    • Community Action Council
    • E-Newsletters
    • BU ADRC Bulletin
    • Donate to Our Cause
  • Education & Outreach
    • REC Scholar Program
    • BU ADRC Lecture Series
    • CTE Conference
    • Student Ambassador Program
    • Development Project Grants
  • For Investigators
  • AD Resources
    • Watch a Lecture Providing an Overview of Alzheimer’s Disease
    • Alzheimer’s Disease FAQs
    • Clinical Care Resources
    • Resources for Clinicians and Providers
    • Resources for Patients, Families and Caregivers
  • CTE Resources
    • Chronic Traumatic Encephalopathy FAQs
    • Donate to Our Cause
    • CTE Research
    • Clinical Care
  • About Us
    • Donate to Our Cause
    • Mission & Cores
    • Our Team
    • Community Partnerships
    • Affiliated Labs
    • Job Openings
    • Contact Us
  • Call Us 617-358-4133
  • Email Us joinadc@bu.edu
Search

Hope remains for fighting Alzheimer’s disease by removing amyloid plaques!

In dramatic turn, Biogen seeks FDA approval for experimental Alzheimer’s drug

Click HERE to learn more.

Hope remains for fighting Alzheimer’s disease by removing amyloid plaques!

Posted6 years ago on Wednesday, October 23rd, 2019 in News, Research Updates

Interested in Research

Interested in Research?

Newsletter

  • Subscribe to The BU ADRC Bulletin to receive biannual updates on BU ADRC

Attend an event

  • RSVP for an upcoming event or browse the archives
Boston University Alzheimer's Disease Research Center
73 E Concord St., Boston, MA 02118
  • BOSTON UNIVERSITY
  • BUMC
  • SEARCH
  • DIRECTORY
  • Job Openings
  • Facebook
  • Twitter
  • YouTube
  • Instagram